Related Experiment Video
Updated: Sep 20, 2026

X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
Published on: May 13, 2020
The 1.15A crystal structure of the Staphylococcus aureus methionyl-aminopeptidase and complexes with triazole based
Christian Oefner1, Alice Douangamath, Allan D'Arcy
1Morphochem AG, WRO-1055/338 Schwarzwaldallee 215, 4058 Basel, Switzerland.
Abstract:
Methionyl aminopeptidases (MetAPs) represent a unique class of protease that are responsible for removing the N-terminal methionine residue from proteins and peptides. There are two major classes of MetAPs (type I and type II) described and each class can be subdivided into two subclasses. Eukaryotes contain both the type I and type II MetAPs, whereas prokaryotes possess only the type I enzyme. Due to the physiological importance of these enzymes there is considerable interest in inhibitors to be used as antiangiogenic and antimicrobial agents. Here, we describe the 1.15A crystal structure of the Staphylococcus aureus MetAP-I as an apo-enzyme and its complexes with various 1,2,4-triazole-based derivatives at high-resolution. The protein has a typical "pita-bread" fold as observed for the other MetAP structures. The inhibitors bind in the active site with the N1 and N2 atoms of the triazole moiety complexing two divalent ions. The 1,2,4-triazols represent a novel class of potent non-peptidic inhibitors for the MetAP-Is.
Insights
Researchers discovered novel 1,2,4-triazole inhibitors for Staphylococcus aureus methionyl aminopeptidases (MetAP-I). These non-peptidic compounds show potential as antimicrobial agents by targeting essential bacterial enzymes.
Area of Science:
- Biochemistry
- Structural Biology
- Microbiology
Background:
- Methionyl aminopeptidases (MetAPs) are crucial proteases removing N-terminal methionine from proteins.
- MetAPs are classified into type I and type II, with eukaryotes having both and prokaryotes possessing only type I.
- Inhibitors of MetAPs are of interest for antiangiogenic and antimicrobial applications.
Purpose of the Study:
- To determine the high-resolution crystal structure of Staphylococcus aureus MetAP-I.
- To investigate the binding of novel 1,2,4-triazole derivatives to MetAP-I.
- To characterize a new class of non-peptidic MetAP inhibitors.
Main Methods:
- X-ray crystallography was used to obtain the 1.15Å crystal structure of Staphylococcus aureus MetAP-I (apo-enzyme).
- Complex structures of MetAP-I with various 1,2,4-triazole derivatives were determined.
- Analysis of inhibitor binding within the enzyme's active site.
Main Results:
- The crystal structure revealed a typical "pita-bread" fold for Staphylococcus aureus MetAP-I.
- 1,2,4-triazole derivatives were observed to bind effectively in the active site.
- The N1 and N2 atoms of the triazole moiety complexed with two divalent ions in the active site.
Conclusions:
- 1,2,4-triazoles represent a novel class of potent, non-peptidic inhibitors for MetAP-I.
- The structural data provides a basis for the rational design of new antimicrobial agents targeting bacterial MetAPs.
- This study elucidates the mechanism of inhibition for this important class of enzymes.
More Related Videos
13:34Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
Published on: December 30, 2016
09:31PCR Mutagenesis, Cloning, Expression, Fast Protein Purification Protocols and Crystallization of the Wild Type and Mutant Forms of Tryptophan Synthase
Published on: September 26, 2020
Related Concept Videos
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance
Antifungal Agents